# Filing Detail

Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-22-138669
Filing Date
2022-05-03
Accepted
2022-05-03 16:06:41
Documents
91
Period of Report
2022-03-31

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | 10-Q | d312501d10q.htm iXBRL | 10-Q | 2420839
2 | EX-10.1 | d312501dex101.htm | EX-10.1 | 1039663
3 | EX-31.1 | d312501dex311.htm | EX-31.1 | 10331
4 | EX-31.2 | d312501dex312.htm | EX-31.2 | 10316
5 | EX-32 | d312501dex32.htm | EX-32 | 4305
11 | GRAPHIC | g312501dsp001.jpg | GRAPHIC | 10748
| Complete submission text file | 0001193125-22-138669.txt |  | 12223883

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
6 | XBRL TAXONOMY EXTENSION SCHEMA | teva-20220331.xsd | EX-101.SCH | 79110
7 | XBRL TAXONOMY EXTENSION CALCULATION LINKBASE | teva-20220331_cal.xml | EX-101.CAL | 46358
8 | XBRL TAXONOMY EXTENSION DEFINITION LINKBASE | teva-20220331_def.xml | EX-101.DEF | 513373
9 | XBRL TAXONOMY EXTENSION LABEL LINKBASE | teva-20220331_lab.xml | EX-101.LAB | 537333
10 | XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE | teva-20220331_pre.xml | EX-101.PRE | 549865
85 | EXTRACTED XBRL INSTANCE DOCUMENT | d312501d10q_htm.xml | XML | 2261472

Mailing Address TEVA PHARMACEUTICAL INDUSTRIES LIMITED 5 BAZEL ST PO B 3190 PETACH TIKVA L3 49131
Business Address 5 BAZEL ST P O B 3190 PETACH TIKVA L3 49131 9729267267
TEVA PHARMACEUTICAL INDUSTRIES LTD (Filer) CIK: 0000818686 (see all company filings)

EIN.: 000000000 | State of Incorp.: L3 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-16174 | Film No.: 22886828
SIC: 2834 Pharmaceutical Preparations